Skip to content
Back to recalls
Drug FDA Class II Ongoing cGMP deviation

Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01

Safecor Health, LLC Published Nov 27, 2024

Risk level

Class II

May cause a temporary or reversible health problem; slight chance of serious harm.

Severity score 60/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact Safecor Health, LLC or your place of purchase with questions, and see the source record below for full details.
Reason for recall

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Affected products (1)

Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01

ASPIRIN · 1470 boxes

NDC: 48433-129, 48433-129-01
Lot codes: 24A0061
Code info: Lot# 24A0061, exp. date 05/23/2026

Affected areas

Nationwide

Timeline

  1. Initiated
    Nov 11, 2024
  2. Published
    Nov 27, 2024
Recall number
D-0058-2025
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.